BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15752284)

  • 1. Evaluation of nitrosative and oxidative stress in Behçet disease.
    Bekpinar S; Kiliç N; Unlüçerçi Y; Akdag-Köse A; Azizlerli G; Ozbek-Kir Z
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):167-71. PubMed ID: 15752284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease.
    Onur E; Kabaroglu C; Inanir I; Var A; Guvenc Y; Gunay O; Gunduz K
    Cutan Ocul Toxicol; 2011 Sep; 30(3):217-20. PubMed ID: 21345164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma.
    Beevi SS; Rasheed MH; Geetha A
    Clin Chim Acta; 2007 Jan; 375(1-2):119-23. PubMed ID: 16889762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients.
    Gokul S; Patil VS; Jailkhani R; Hallikeri K; Kattappagari KK
    Oral Dis; 2010 Jan; 16(1):29-33. PubMed ID: 19656315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
    Harzallah O; Kerkeni A; Baati T; Mahjoub S
    Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
    Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
    Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum carbonyl and malondialdehyde levels following colchicine and vitamin E treatment in Behcet's disease.
    Gulbahar O; Adisen H; Koca C; Aricioglu A; Gulekon A
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):521-4. PubMed ID: 18040527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer.
    Arsova-Sarafinovska Z; Eken A; Matevska N; Erdem O; Sayal A; Savaser A; Banev S; Petrovski D; Dzikova S; Georgiev V; Sikole A; Ozgök Y; Suturkova L; Dimovski AJ; Aydin A
    Clin Biochem; 2009 Aug; 42(12):1228-35. PubMed ID: 19465015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.
    Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F
    Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
    Baskol G; Atmaca H; Tanriverdi F; Baskol M; Kocer D; Bayram F
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):522-6. PubMed ID: 17853336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen metabolites: a link between oxidative stress and inflammation in patients on hemodialysis.
    Samouilidou E; Grapsa E; Karpouza A; Lagouranis A
    Blood Purif; 2007; 25(2):175-8. PubMed ID: 17215574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sister chromatid exchange and micronucleus studies in patients with Behçet's disease.
    Karaman A; Kadi M; Kara F
    J Cutan Pathol; 2009 Aug; 36(8):831-7. PubMed ID: 19159395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis.
    Serarslan G; Yilmaz HR; Söğüt S
    Clin Exp Dermatol; 2005 May; 30(3):267-71. PubMed ID: 15807687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis.
    Lamsal M; Gautam N; Bhatta N; Toora BD; Bhattacharya SK; Baral N
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):695-703. PubMed ID: 17883009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease.
    Barreiro E; de la Puente B; Minguella J; Corominas JM; Serrano S; Hussain SN; Gea J
    Am J Respir Crit Care Med; 2005 May; 171(10):1116-24. PubMed ID: 15735057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.